Opinion: considerably undervalued at 6 cents
Reasons: Market cap of other MM stocks compared to MXC progress / achievements, revenue growth and market recognition via derma has been a real success - potential buyout target, the co. entering critical period post GMP for pharma - Cannepil = cash on the table, Europe market is beckoning, large and years post legalisation. The neurologist coming onto staff is critical - all signs, in spite of the scars (VC the biggest gash) and churn along the way, point firmly to u n d e r v a l u e d
- Forums
- ASX - By Stock
- RGT
- MGC - The Forgotten Updates
MGC - The Forgotten Updates, page-10
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
(20min delay)
|
|||||
Last
50.5¢ |
Change
-0.045(8.18%) |
Mkt cap ! $24.44M |
Open | High | Low | Value | Volume |
50.0¢ | 50.5¢ | 50.0¢ | $276 | 550 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 50.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
53.0¢ | 155 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 0.505 |
1 | 1000 | 0.470 |
1 | 25000 | 0.400 |
1 | 1000 | 0.360 |
1 | 2000 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.530 | 155 | 2 |
0.550 | 3172 | 3 |
0.570 | 9955 | 2 |
0.575 | 650 | 1 |
0.590 | 2000 | 1 |
Last trade - 13.29pm 07/10/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |